Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:Read more
Four MSK researchers out of 15 winners nationwide were named recipients of the prestigious award. They will each receive a grant of up to $600,000 per year for seven years to support their research in cancer.Read more
Neuro-oncologist and renowned physician-scientist Ingo Mellinghoff will lead MSK’s distinguished Department of Neurology after previously serving as Acting Co-Chair.Read more
Computational biologist Thomas Norman, PhD, of Memorial Sloan Kettering’s (MSK) Sloan Kettering Institute (SKI) has been named one of 53 recipients of the prestigious 2020 National Institutes of Health (NIH) Director’s New Innovator Award. As part of the award, Dr. Norman will receive $1.5 million in direct costs upfront in the first year of a five-year award.Read more
Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by U.S. News & World Report in its annual Best Hospitals listing.
Since U.S. News & World Report established the prestigious rankings more than 30 years ago, MSK has earned either the first or second spot for best cancer care in the country each year.
A team of researchers at Memorial Sloan Kettering Cancer Center (MSK) reported on the epidemiology of COVID-19 illness experienced at an NCI-designated cancer center during the height of pandemic in New York City.Read more
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and honors to our staff, given by the American Association for Cancer Research (AACR), the American Society of Clinical Oncology (ASCO), and the American Society of Hematology (ASH) organizations.Read more
On Thursday, June 18, at 6:00 p.m. E.T. with an encore at 9:00 p.m., Memorial Sloan Kettering Cancer Center (MSK) will stream a special performance on visibleink.vimeo.mskcc.org, highlighting poignant and humorous perspectives On Cancer and Coronavirus, featuring works from its writing program, Visible Ink. This will be the 12th annual performance of stories written by MSK patients, and the first presented virtually. Visible Ink has always worked with many participants remotely, so it was well positioned to continue to connect MSK patients with experienced writers to support their written expression.Read more